FDA NDC Directory · JSON-LD · Markdown
NDC 81894-102 · HUMAN PRESCRIPTION DRUG · SOLUTION
| Labeler / Manufacturer | Luoxin Aurovitas Pharma (Chengdu) Co., Ltd. |
|---|---|
| Marketing category | Abbreviated NDA (generic) · App ANDA207625 |
| Dosage form / route | SOLUTION · RESPIRATORY (INHALATION) |
| Active ingredients | LEVALBUTEROL HYDROCHLORIDE (.63 mg/3mL) |
| Marketing started | 20161230 |
| Package count | 1 |
Source: openFDA. Public-domain (CC0).